Dana Investment Advisors, Inc. Abbott Laboratories Transaction History

Dana Investment Advisors, Inc.

$2.99 Billion
Q3 2024

A detailed history of Dana Investment Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Dana Investment Advisors, Inc. holds 61,218 shares of ABT stock, worth $7.04 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

61,218

Previous 70,393 13.03%

Holding current value

$7.04 Million

Previous $7.31 Million 4.58%

% of portfolio

0.23%

Previous 0.25%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $918,142 - $1.08 Million	-9,175 Reduced 13.03%	61,218 $6.98 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $241,852 - $269,968	-2,401 Reduced 3.3%	70,393 $7.31 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $657 - $725	6 Added 0.01%	72,794 $8.27 Million
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $34,452 - $42,172	-382 Reduced 0.52%	72,788 $8.01 Million
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $3.47 Million - $4.16 Million	-36,286 Reduced 33.15%	73,170 $7.09 Million
Q2 2023 Aug 15, 2023	SELL	$100.78 - $112.29 $606,594 - $675,873	-6,019 Reduced 5.21%	109,456 $11.9 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $12.7 Million - $15 Million	-131,430 Reduced 53.23%	115,475 $11.7 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $1.21 Million - $1.42 Million	12,736 Added 5.44%	246,905 $27.1 Million
Q3 2022 Nov 15, 2022	SELL	$96.76 - $112.03 $765,952 - $886,829	-7,916 Reduced 3.27%	234,169 $22.7 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $5.61 Million - $6.78 Million	54,943 Added 29.36%	242,085 $26.3 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $1.14 Million - $1.39 Million	9,980 Added 5.63%	187,142 $22.2 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $1.72 Million - $2.11 Million	-14,931 Reduced 7.77%	177,162 $24.9 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $674,294 - $745,966	-5,780 Reduced 2.92%	192,093 $22.7 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $1.06 Million - $1.25 Million	-10,066 Reduced 4.84%	197,873 $22.9 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $447,767 - $527,538	4,114 Added 2.02%	207,939 $24.9 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $680,295 - $741,327	6,479 Added 3.28%	203,825 $22.3 Million
Q3 2020 Nov 10, 2020	BUY	$91.64 - $111.29 $1.29 Million - $1.56 Million	14,062 Added 7.67%	197,346 $21.5 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $199,924 - $255,878	-2,611 Reduced 1.4%	183,284 $16.8 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $9.47 Million - $13.8 Million	150,724 Added 428.55%	185,895 $14.7 Million
Q4 2019 Feb 11, 2020	SELL	$78.51 - $87.4 $165,970 - $184,763	-2,114 Reduced 5.67%	35,171 $3.06 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $521,730 - $565,717	6,375 Added 20.62%	37,285 $3.12 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $2.25 Million - $2.63 Million	30,910 New	30,910 $2.6 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $3.57 Million - $4.32 Million	-53,980 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $95,193 - $107,840	-1,452 Reduced 2.62%	53,980 $3.9 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $92,978 - $112,167	1,529 Added 2.84%	55,432 $4.07 Million
Q2 2018 Aug 01, 2018	SELL	$57.57 - $63.54 $741,444 - $818,331	-12,879 Reduced 19.29%	53,903 $0
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $1.56 Million - $1.76 Million	27,691 Added 70.84%	66,782 $4 Million
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $2.1 Million - $2.25 Million	39,091	39,091 $0

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dana Investment Advisors, Inc. with notifications on news.

Account

Dana Investment Advisors, Inc. Abbott Laboratories Transaction History